Portal de Periódicos da CAPES

Clinical Evidence of Systemic Persistence of Bacillus Calmette-Guerin: Long-Term Pulmonary Bacillus Calmette-Guerin Infection After Intravesical Therapy for Bladder Cancer and Subsequent Cystectomy

1992; Lippincott Williams & Wilkins; Volume: 148; Issue: 6 Linguagem: Inglês

10.1016/s0022-5347(17)37063-5

1527-3792

Andreas Böhle, D Kirsten, Kristin Schröder, A. Knipper, Paolo Fornara, H Magnussen, D. Jocham,

Urinary Tract Infections Management

No AccessJournal of Urology1 Dec 1992Clinical Evidence of Systemic Persistence of Bacillus Calmette-Guerin: Long-Term Pulmonary Bacillus Calmette-Guerin Infection After Intravesical Therapy for Bladder Cancer and Subsequent Cystectomy A. Böhle, D. Kirsten, K.-H. Schröder, A. Knipper, P. Fornara, H. Magnussen, and D. Jocham A. BöhleA. Böhle More articles by this author , D. KirstenD. Kirsten More articles by this author , K.-H. SchröderK.-H. Schröder More articles by this author , A. KnipperA. Knipper More articles by this author , P. FornaraP. Fornara More articles by this author , H. MagnussenH. Magnussen More articles by this author , and D. JochamD. Jocham More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(17)37063-5AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail A patient with urothelial bladder carcinoma is reported who suffered from culture proved pulmonary bacillus Calmette-Guerin (BCG) infection 14 months after a single course of intravesical BCG and 11 months after subsequent radical cystectomy for progressive cancer. This unusual case raises the question of the ultimate fate of intravesically instilled BCG and the possible persistence of these mycobacteria in remote organs. Systemic spread and dormant survival at least in some cases are suggested, and therapeutic and diagnostic consequences are discussed. © 1992 by The American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited ByDUREK C, RICHTER E, BASTECK A, RÜSCH-GERDES S, GERDES J, JOCHAM D and BÖHLE A (2018) THE FATE OF BACILLUS CALMETTE-GUERIN AFTER INTRAVESICAL INSTILLATIONJournal of Urology, VOL. 165, NO. 5, (1765-1768), Online publication date: 1-May-2001.KIM J and STEINBERG G (2018) THE LIMITS OF BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDERJournal of Urology, VOL. 165, NO. 3, (745-756), Online publication date: 1-Mar-2001.Soloway M (2018) Editorial: Intravesical Therapy for Bladder CancerJournal of Urology, VOL. 152, NO. 2 Part 1, (379-381), Online publication date: 1-Aug-1994.Izes J, Bihrle W and Thomas C (2018) Corticosteroid-Associated Fatal Mycobacterial Sepsis Occurring 3 Years after Instillation of Intravesical Bacillus Calmette-GuerinJournal of Urology, VOL. 150, NO. 5 Part 1, (1498-1500), Online publication date: 1-Nov-1993. Volume 148Issue 6December 1992Page: 1894-1897 Advertisement Copyright & Permissions© 1992 by The American Urological Association Education and Research, Inc.KeywordsBCG vaccinecomplicationsimmunotherapymycobacteriabladder neoplasmsMetricsAuthor Information A. Böhle More articles by this author D. Kirsten More articles by this author K.-H. Schröder More articles by this author A. Knipper More articles by this author P. Fornara More articles by this author H. Magnussen More articles by this author D. Jocham More articles by this author Expand All Advertisement Loading ...